More on Myriad Genetics (MYGN +8.9%): The mixed ruling was not a surprise to many, as the Court expressed skepticism over whether human DNA extracted from the body could be patented like a mechanical invention during arguments in April. Nevertheless, it removes an overhang for the sector. Read more here: (Supreme Court Ruling).
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Mon, 8:47AM)
at Benzinga.com (Feb 25, 2015)
at Nasdaq.com (Feb 12, 2015)
at Nasdaq.com (Jan 29, 2015)
at Nasdaq.com (Jan 22, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs